Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.

Auteurs : Kourie HR, Ameye L, Paesmans M, Bron D
Jaar : 2016
Journal : Ann Hematol
Volume : 95(12)
Pagina's : 2105-2106

Vulnerabilities in Older Patients when Cancer Treatment is Initiated: Does a Cognitive Impairment Impact the Two-Year Survival?

Auteurs : Libert Y, Dubruille S, Borghgraef C, Etienne AM, Merckaert I, Paesmans M, Reynaert C, Roos M, Slachmuylder JL, Vandenbossche S, Bron D, Razavi D
Jaar : 2016
Journal : PLoS One
Volume : 11
Pagina's : e0159734

Data on nitric oxide production by human bone marrow-derived mesenchymal stromal cells.

Auteurs : Najar M, Fayyad-Kazan M, Fayyad-Kazan H, Meuleman N, Bron D, Lagneaux L
Jaar : 2016
Journal : Data Brief
Volume : 8
Pagina's : 1111-4

Innovative approach to older patients with malignant hemopathies.

Auteurs : Bron D, Soubeyran P, Fulop T
Jaar : 2016
Journal : Haematologica
Volume : 101
Pagina's : 893-5

Costs of haematological disease high and rising.

Auteurs : Green T, Bron D, Chomienne C, de Wit TD, de Haas F, Engert A, Hagenbeek A, Jäger U, MacIntyre E, Muckenthaler MU, Smand C, Sonneveld P
Jaar : 2016
Journal : Lancet Haematol
Volume : 3
Pagina's : e353-4

Diagnosis of congenital von Willebrand disease during a preoperative assessment in a multiple myeloma patient without bleeding history.

Auteurs : El Ouaaliti M, Li R, Gobin D, Bron D, Cantinieaux B
Jaar : 2016
Journal : Clin Case Rep
Volume : 4
Pagina's : 703-6

Onco-haematology geriatry : impact of cognitive disorders.

Auteurs : Dubruille S, Libert Y, Razavi D, Bron D
Jaar : 2016
Journal : Belgian J Hematology
Volume : 7
Pagina's : 180-3

BHS guidelines for the treatment of large granular lymphocyte and cronic prolymphocytic leukaemias

Auteurs : Delrieu V, Wu KL, Schroyens W, Bonnet C, Bron D, Janssens A
Jaar : 2016
Journal : Belgian J Hematology
Volume : 7
Pagina's : 103-11

Severe Prolonged Cough as Presenting Manifestation of FIP1L1-PDGFRA+ Chronic Eosinophilic Leukaemia: A Widely Ignored Association.

Auteurs : Roufosse F, Heimann P, Lambert F, Sidon P, Bron D, Cottin V, Cordier JF
Jaar : 2016
Journal : Respiration
Volume : 91
Pagina's : 374-9

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.

Auteurs : Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, Casasnovas O, Van Den Neste E, Dechene J, De Maertelaer V, Bron D, Englert Y
Jaar : 2016
Journal : J Clin Oncol
Volume : 34(22)
Pagina's : 2568-74

Corrigendum to Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicenter prospective study" [J. Geriatr. Oncol. 6 (2015) 401-410]."

Auteurs : Baitar A, Kenis C, Moor R, Decoster L, Luce S, Bron D, Van Rijswijk R, Rasschaert M, Langenaeken C, Jerusalem G, Lobelle JP, Flamaing J, Milisen K, Wildiers H
Jaar : 2016
Journal : J Geriatr Oncol
Volume : 7
Pagina's : 142-143

Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study.

Auteurs : Gratwohl A, Iacobelli S, Bootsman N, van Biezen A, Baldomero H, Arcese W, Arnold R, Bron D, Cordonnier C, Ernst P, Ferrant A, Frassoni F, Gahrton G, Richard C, Kolb HJ, Link H, Niederwieser D, Ruutu T, Schattenberg A, Schmitz N, Torres-Gomez A, Zwaan F, Apperley J, Olavarria E, Kröger N
Jaar : 2016
Journal : Ann Hematol
Volume : 95(6)
Pagina's : 967-72

Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis.

Auteurs : Kourie HR, Ameye L, Paesmans M, Bron D
Jaar : 2016
Journal : Clin Lymphoma Myeloma Leuk
Volume : 16(5)
Pagina's : 264-8

Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties.

Auteurs : Najar M, Raicevic G, André T, Fayyad-Kazan H, Pieters K, Bron D, Toungouz M, Lagneaux L
Jaar : 2016
Journal : Cytotherapy
Volume : 18
Pagina's : 320-35

The Immunomodulatory Potential of Mesenchymal Stromal Cells: A Story of a Regulatory Network.

Auteurs : Najar M, Raicevic G, Crompot E, Fayyad-Kazan H, Bron D, Toungouz M, Lagneaux L
Jaar : 2016
Journal : J Immunother
Volume : 39
Pagina's : 45-59

Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells.

Auteurs : Najar M, Raicevic G, Fayyad-Kazan H, Bron D, Toungouz M, Lagneaux L
Jaar : 2016
Journal : Cytotherapy
Volume : 18
Pagina's : 160-71

Current management of marginal zone lymphomas.

Auteurs : Bonnet C, Lejeune M, Van Kemseke C, Bron D, Beguin Y
Jaar : 2015
Journal : Rev Med Suisse
Volume : 11
Pagina's : 1549-56

Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013).

Auteurs : de Witte T, Suciu S, Meert L, Halkes C, Selleslag D, Bron D, Amadori S, Willemze R, Muus P, Baron F
Jaar : 2015
Journal : Ann Hematol
Volume : 94
Pagina's : 1981-9

Practical approach of lymphomas: major role of general practitioner who has to face all these emerging drugs].

Auteurs : Bron D, de Wind R, Cantinieaux B, Woff E, Roelandts M, Moerman C, Lemort M, Heimann P, de Wilde V, Meuleman N, Maerevoet M
Jaar : 2015
Journal : Rev Med Brux
Volume : 36
Pagina's : 237-47

Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition.

Auteurs : Dubruille S, Libert Y, Roos M, Vandenbossche S, Collard A, Meuleman N, Maerevoet M, Etienne AM, Reynaert C, Razavi D, Bron D
Jaar : 2015
Journal : J Geriatr Oncol
Volume : 24(3)
Pagina's : 294-301